Medtronic plc, a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence...
National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan...
Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer fo...
Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the...
Leading European life sciences investment firm Medicxi has announced the closing of Medicxi III, a new €400 million...
Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston,...
TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for bette...
Exicure, a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs...
Recursion, a next-gen biopharma company combining automated, experimental biology with artificial intelligence to discov...
Illumina has announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the Sa...
Gilead Sciences and the Renown Institute for Health Innovation (IHI) have announced a strategic collaboration to co...
Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Compa...
An injection of nanoparticles can prevent the body’s immune system from overreacting to trauma, potentially preven...
Abbott has announced that U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinit...
US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year globa...
Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market a...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with aut...
